Are These Stocks a Buy or Sell? ( PPHM, LEN, ALKS, BGS )

Los Angelas, CA -- (SBWIRE) -- 09/24/2012 -- Peregrine Pharmac (NCM:PPHM) are trading at $5.39 and is +74.98% from its 50-day Moving Average price of $3.0803 and +322.04% from its 200-day Moving Average price of $1.2771. The average trading volume is 4448800 shares and its market capitalization is $561.6M.Peregrine Pharmaceuticals(NASDAQ:PPHM) shares jumped 2.86% and closed at $5.03 in the last trading session. Equities research analysts at Roth Capital increased their price target on shares of Peregrine from $5.00 to $9.00 in a research note issued to investors on Sept. 10. Additionally, analysts predict that PPHM will post $0.00 earnings per share for the current fiscal year.

How Should Investors React To PPHM Now? Find Out Here

Lennar Corporatio (NYSE:LEN) are trading at $37.51 and is +13.99% from its 50-day Moving Average price of $32.9051 and +29.80% from its 200-day Moving Average price of $28.8991. The average trading volume is 5292740 shares and its market capitalization is $7.101B.Lennar Corp. (LEN), the third-largest U.S. homebuilder by revenue, said fiscal third-quarter earnings more than quadrupled as demand for new houses climbed. Net income for the three months through August rose to $87.1 million, or 40 cents a share, from $20.7 million, or 11 cents, a year earlier, the Miami-based company said today in a statement. The average estimate (LEN) of 19 analysts in a Bloomberg survey was for earnings of 28 cents a share.Purchases of new homes in the U.S. have begun to rebound as low mortgage rates help lure buyers amid a tight supply of existing properties. Builders broke ground on new single-family homes at anannual pace of 535,000 in August, the highest rate since April 2010, when buyers rushed to take advantage of federal tax credits designed to stimulate the market, the Commerce Department reported Sept. 19.

How Should Investors React To LEN Now? Find Out Here

Alkermes plc (NasdaqNM:ALKS) are trading at $20.52 and is +11.08% from its 50-day Moving Average price of $18.474 and +16.92% from its 200-day Moving Average price of $17.5509. The average trading volume is 1100970 shares and its market capitalization is $2.685B.Alkermes (ALKS), which develops drugs to treat central nervous system disorders, is in buying range after breaking out of a cup-without-handle base. The stock is 2% above the 20.09 buy point, putting it well within the 5% limit that defines a buy area. It broke out Thursday in volume that was just 12% above average, but turnover picked up sharply Friday as the stock rose for the seventh straight session. Alkermes, based in Waltham, Mass., last year bought Ireland's Elan Drug Technologies for about $1 billion in stock and cash. That gave it a stable of new products, including Invega Sustenna for the treatment of schizophrenia. Bydureon, a drug Alkermes developed to treat type 2 diabetes, is also expected to provide a strong lift.

How Should Investors React To ALKS Now? Find Out Here

Shares of B&G Foods, Inc. B (NYSE:BGS) are trading at $31.75 and is +7.40% from its 50-day Moving Average price of $29.5614 and +24.65% from its 200-day Moving Average price of $25.4706. The average trading volume is 374281 shares and its market capitalization is $1.536B. Shares of B&G Foods (NYS: BGS) hit a 52-week high on Thursday. Let's take a look at how it got there and see whether clear skies are still in the forecast. B&G Foods, a provider of shelf-stable foods and the name behind such brands as Emeril's, Ortega, Mrs. Dash, and Cream of Wheat, has been utilizing its keen eye for a good deal to grow its bottom line and product portfolio through acquisitions over the last couple of years.

How Should Investors BGS To ALKS Now? Find Out Here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com